Vgofil is a phosphodiesterase type 5 (PDE5) inhibitor used in the management of erectile dysfunction in adult men. It works by enhancing blood flow to the penile tissue during sexual stimulation through relaxation of smooth muscles and improved vascular response. This helps achieve and maintain a satisfactory erection, supporting improved sexual performance and confidence. Vgofil is indicated for men experiencing difficulty in attaining or sustaining erections due to impaired penile blood circulation. By targeting the underlying vascular mechanism, it provides effective symptomatic management of erectile dysfunction. Vgofil is commonly used as part of overall sexual health care, helping improve intimate relationships and quality of life in affected individuals.